Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide ...
Prelog also discussed personalized vaccines for cancer immunotherapy. Personalized mRNA vaccines are tailored to the ...
MyChesCo on MSN3h
Arbutus Biopharma Makes Headway in Hepatitis B Treatment and Defends Intellectual Property Amidst Q1 2024 Financial ReleaseArbutus Biopharma Corporation (Nasdaq: ABUS) has unveiled its growth during the first quarter of 2024, particularly in the ...
MedPage Today on MSN1d
FDA Says Dairy Products Like Cottage Cheese Are SafeAdditional preliminary testing by the FDA has found that retail milk products such as cottage cheese and sour cream don't ...
The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who ...
ImmunityBio, Inc. (NASDAQ: IBRX), has signed an exclusive global arrangement with the Serum Institute of India, the world’s ...
Zacks.com on MSN14h
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/YMRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the Zacks Consensus Estimate of a loss of $3.59. In the year-ago period, management posted earnings of 19 cents per ...
“Whether they need help with their clinical trial, we've got capabilities that support that. If you need help making your ...
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback